Plasma pTau181 predicts Alzheimer’s progression in real-world memory clinic patients

Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.

Study finds link between poor mental health and browsing negative online content

People with poorer mental health are more prone to browsing negative content online, which further exacerbates their symptoms, finds a study led by UCL researchers.

November 21, 2024

Vertex pain drug results met with measured optimism — and questions — by observers and experts

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief.

January 30, 2024

IGEA to update on SIX decision – Biotech Investments

IGEA Pharma N.V. / Key word(s): Delisting/Delisting 04-Aug-2023 / 22:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

August 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.